ALPHACENTRIC ADVISORS LLC
Q1 2024 Form 13-F
SAN JUAN, PUERTO RICO
CIK 0001913464
· CRD 170679
· SEC-registered investment adviser
$165.8M Reported Value Total
ALPHACENTRIC ADVISORS LLC reports 7 total accounts under management (AUM). There are 7 discretionary accounts valued at $728,151,543, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Source: Form ADV filed 2026-06-02
Reported value
$165.8M
Quarter over quarter
-1.7%
Holdings
228
Top-10 concentration
22.2%
Key People
Form ADV owners & control persons
David Scott Miller
MEMBER
Jerry John Szilagyi
MANAGING MEMBER
Michael Thomas Schoonover
MEMBER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q1 2024 13F record
Q1 2024 13F filing summary
| Period of report | March 31, 2024 |
|---|---|
| Filed | April 24, 2024 |
| Form | 13F-HR |
| Reported value | $165.8M |
| Positions | 228 |
| Change in reported value | +11.3% |
| New positions | 38 |
| Exited positions | 26 |
| Position turnover | 25.2% |
| Top-10 concentration | 22.2% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 3, 2026
|
245 | $112.6M |
|
Q2 2026 13F
Filed Jul 24, 2026
|
259 | $118.0M |
|
Q1 2026 13F
Filed May 7, 2026
|
252 | $100.1M |
|
Q4 2025 13F
Filed Feb 12, 2026
|
249 | $100.3M |
|
Q4 2024 13F
Filed Jan 31, 2025
|
209 | $100.2M |
|
Q3 2024 13F
Filed Oct 30, 2024
|
230 | $134.5M |
|
Q2 2024 13F
Filed Jul 25, 2024
|
217 | $135.8M |
|
Q1 2024 13F
Filed Apr 24, 2024
|
228 | $165.8M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
216 | $149.0M |
|
Q3 2023 13F
Filed Nov 13, 2023
|
234 | $176.3M |
|
Q2 2023 13F
Filed Aug 8, 2023
|
231 | $180.2M |
|
Q1 2023 13F
Filed May 12, 2023
|
209 | $144.9M |
|
Q4 2022 13F
Filed Feb 7, 2023
|
165 | $101.2M |
|
Q3 2022 13F
Filed Nov 8, 2022
|
184 | $97.4M |
|
Q4 2021 13F
Filed Feb 25, 2022
|
220 | $343.1M |
6 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q1 2024
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | PFE PFIZER INC | $4.9M | 2.93% |
| 2 | RITM RITHM CAPITAL CORP | $4.7M | 2.83% |
| 3 | HRMY HARMONY BIOSCIENCES HLDGS IN | $4.1M | 2.47% |
| 4 | UTHR UNITED THERAPEUTICS CORP DEL | $3.7M | 2.22% |
| 5 | PCRX PACIRA BIOSCIENCES INC | $3.4M | 2.07% |
| 6 | BCRX BIOCRYST PHARMACEUTICALS INC | $3.4M | 2.07% |
| 7 | LKFT GALAPAGOS NV | $3.4M | 2.04% |
| 8 | ARGX ARGENX SE | $3.1M | 1.9% |
| 9 | TWO 6.25 01/15/26 TWO HARBORS INVENTMENT CORPO | $3.0M | 1.84% |
| 10 | NARI INARI MED INC | $3.0M | 1.82% |
| 11 | DCGO DOCGO INC | $2.6M | 1.58% |
| 12 | ONC BEIGENE LTD | $2.6M | 1.58% |
| 13 | EFC ELLINGTON FINANCIAL INC | $2.6M | 1.58% |
| 14 | AXSM AXSOME THERAPEUTICS INC | $2.6M | 1.56% |
| 15 | MTG MGIC INVT CORP WIS | $2.6M | 1.54% |
| 16 | QURE UNIQURE NV | $2.4M | 1.44% |
| 17 | CHRS COHERUS BIOSCIENCES INC | $2.4M | 1.44% |
| 18 | MIRM MIRUM PHARMACEUTICALS INC | $2.4M | 1.42% |
| 19 | DX DYNEX CAP INC | $2.3M | 1.36% |
| 20 | URGN UROGEN PHARMA LTD | $2.2M | 1.3% |
Values as reported on the Q1 2024 Form 13F. Every position is in the holdings table below.